title: Anti-TNF-alpha-induced psoriasis: case report of an unusual adverse event.
authors.forename: Spyros
authors.initials: S
authors.lastname: Aslanidis
authors.forename: Athina
authors.initials: A
authors.lastname: Pyrpasopoulou
authors.forename: Maria
authors.initials: M
authors.lastname: Leontsini
authors.forename: Chryssanthos
authors.initials: C
authors.lastname: Zamboulis
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000276:immunology* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab